Assessing Sionna Therapeutics (SION) Valuation As Premium P/B Meets Cooling Share Price Momentum [Yahoo! Finance]
Sionna Therapeutics, Inc. (SION)
Company Research
Source: Yahoo! Finance
Sionna Therapeutics (SION) has drawn attention after recent trading, with the share price closing at $38. For investors tracking performance, returns over the past week, month and past 3 months show mixed moves. See our latest analysis for Sionna Therapeutics. That recent softness in the 1 month share price return of 12.44% and 3 month share price return of 12.78%, despite a 1 year total shareholder return of around 2.6x, suggests some of the earlier enthusiasm has cooled as investors reassess both upside potential and risks at the current US$38 level. If Sionna's moves in biotech are on your radar and you want to widen your watchlist, this could be a good moment to check out 29 healthcare AI stocks as a fresh set of ideas. So with Sionna's shares cooling over the past 3 months but still delivering a 1 year total return of around 2.6x, is today's US$38 price a reset that leaves upside on the table, or is the market already baking in future growth? Preferred Price-to-Book Mu
Show less
Read more
Impact Snapshot
Event Time:
SION
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SION alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SION alerts
High impacting Sionna Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SION
News
- Sionna Therapeutics (SION) had its "buy" rating reaffirmed by UBS Group AG.MarketBeat
- Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.MarketBeat
- Sionna Therapeutics (SION) had its "buy" rating reaffirmed by BTIG Research. They now have a $58.00 price target on the stock.MarketBeat
- Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
SION
Earnings
- 11/5/25 - Beat
SION
Sec Filings
- 3/5/26 - Form 144
- 3/2/26 - Form S-8
- 3/2/26 - Form S-3ASR
- SION's page on the SEC website